Compare Genuine Parts Company (GPC) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genuine Parts Company vs Moderna, Inc. — how do they compare? Genuine Parts Company trades at $135.22 (market cap $18.62B), while Moderna, Inc. trades at $60.75 (market cap $24.18B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Genuine Parts Company pays a 3.15% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| GPC | MRNA | |
|---|---|---|
Market Cap | $18.62B | $24.18B |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $81.80 |
52-Week Low | $92.47 | $22.36 |
Enterprise Value | $24.72B | $20.33B |
Dividend Yield | 3.15% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
